Skip to content

Constellium CSTM Stock options excluded as their inclusion would be anti-dilutive (in shares)

Stock options excluded as their inclusion would be anti-dilutive (in shares) at other companies

Valvoline logo
ValvolineVVV
600K+500%
Repligen logo
RepligenRGEN
520K+27.1%
Corebridge Financial logo
Corebridge FinancialCRBG
3.6M+800%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
305.6M+138%
Equitable Holdings logo
Equitable HoldingsEQH
1.2M-36.8%
Wingstop logo
WingstopWING
98K+1,125%

Other financials

Income statement

See full
Revenue$2.5B+24.4%
Gross profit$420.0M+59.7%
Net income$199.0M+438%
EPS (diluted)$1.42+446%

Balance sheet

See full
Cash & equivalents$143.0M+21.2%
Total debt$2.0B-4.1%
Total equity$1.1B+50.2%
Total assets$5.8B+13.1%

Cash flow

See full
Operating cash flow$73.0M+25.9%
CapEx$72.0M+4.3%
Free cash flow$1.0M+109%

Valuation

See full
Market cap$4.63B+129%

Profitability

See full
Gross margin15%+2.2pp
Net margin4.9%
FCF margin1.9%+1.4pp

Returns & leverage

See full
Return on equity46.7%
Debt / equity1.8×-1.0×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by Constellium in its filing.

Tagged under the XBRL concept us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.

The official record: Constellium’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Constellium's stock options excluded as their inclusion would be anti-dilutive (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Constellium's stock options excluded as their inclusion would be anti-dilutive (in shares)?
Constellium (CSTM) reported stock options excluded as their inclusion would be anti-dilutive (in shares) of 0 in Q1 2026.
What does stock options excluded as their inclusion would be anti-dilutive (in shares) mean?
Represents the number of potentially dilutive financial instruments, such as stock options or warrants, excluded from the diluted earnings per share calculation because their exercise price exceeds the average market price of the company's stock. Including these instruments would result in an increase in earnings per share, which is mathematically inconsistent with the purpose of diluted EPS. Monitoring this figure helps investors understand the potential future dilution impact if market conditions change.